Mäkelä P, Dean P B
Eur J Radiol. 1986 Nov;6(4):303-4.
The frequency of hyperamylasemia was examined in 88 consecutive patients undergoing ERCP (endoscopic retrograde cholangio-pancreaticography) using either meglumine diatrizoate at 306 mgI/ml., or iohexol at 240 mgI/ml. There was no difference in the incidence of hyperamylasemia between these two groups of patients, nor did any other factors appear to influence its occurrence. The authors conclude that acute hyperamylasemia after ERCP is a complication of relatively minor importance unlikely to be reduced by the use of low osmolality contrast media.
对88例连续接受内镜逆行胰胆管造影术（ERCP）的患者进行了高淀粉酶血症发生率的检查，这些患者分别使用了306mgI/ml的泛影葡胺或240mgI/ml的碘海醇。这两组患者高淀粉酶血症的发生率没有差异，似乎也没有任何其他因素影响其发生。作者得出结论，ERCP术后急性高淀粉酶血症是一种相对不太重要的并发症，使用低渗造影剂不太可能降低其发生率。
